What is it about?
obese patients treated with UDCA before surgery showed changes in lipid homeostasis and bile acid signaling by UDCA antagonizing FXR
Featured Image
Why is it important?
a new research showing that FXR modulation by endogenous bile acids is possible in morbid obese
Read the Original
This page is a summary of: Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity, Journal of Hepatology, June 2015, Elsevier,
DOI: 10.1016/j.jhep.2014.12.034.
You can read the full text:
Contributors
The following have contributed to this page
